https://www.letlifehappen.com/lilly-announces-publication-of-analyses-showing-benefit-of-the-addition-of-verzenio-abemaciclib-in-multiple-subgroups-of-patients-with-advanced-breast-cancer-identified-as-having-a-more-concer/
Lilly announces publication of analyses showing benefit of the addition of Verzenio® (abemaciclib) in multiple subgroups of patients with advanced breast cancer identified as having a more concerning prognosis